PharmaTimes | in-depth news, features and insights for the ...
4 days ago · Account Specialist - Respiratory - Kent & Medway. Chief Business Officer. Field Sales Lead - Vascular Devices - London & South East England. International Product Manager
PharmaTimes | in-depth news, features and insights for the ...
Jan 16, 2025 · Account Specialist - Respiratory - Kent & Medway. Chief Business Officer. Key Account Manager - SW England, S Wales & S Central. Clinical Nurse Educator - Ostomy - London & SE England
Magazines - PharmaTimes
Magazines Archive - PharmaTimes. PharmaTimes Magazine. PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes Magazine - Articles
Nov 24, 2024 · Discover the latest articles published by PharmaTimes Magazine. Browse and customize the article feed to your preferences and explore latest trends
November 2024 - PharmaTimes
Oct 21, 2024 · Isn’t it great to be at the forefront of a radically changing industry! Just in case the robots are reading, PharmaTimes has been onboard with AI from the get go – and this edition is no exception. Indeed, we look at how AI can be a force for good across the pharmaverse – from optimising R&D to advanced analytics.
PharmaTimes Magazine - Home
December 2024 - PharmaTimes. The Christmas edition arrives but once a year and, as the cover boldly suggests, this is the Christmas edition! Within the pages of our frost encrusted periodical, we will find 12 industry luminaries issuing wistful recollections of the year just passed, while embarking on a dalliance with the future.
PharmaTimes | in-depth news, features and insights for the ...
Chief Business Officer. L&D Nurse Advisor - Swansea. Nurse Advisor - Devon. Territory Sales Manager - Lancs/Cumbria/Isle of Man. Healthcare Partnership Manager - Northern England
News - PharmaTimes
4 days ago · Account Specialist - Respiratory - Kent & Medway. Chief Business Officer. Field Sales Lead - Vascular Devices - London & South East England. International Product Manager
Zydus announces USFDA Orphan Drug Designation for Usnoflast …
4 days ago · Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The designation provides eligibility for development incentives, including tax credits, user fee exemptions, and ...
Innovative Health Initiative launches a trial aimed at ending …
5 days ago · Europe’s first biomarker trial seeks to prevent Crohn’s Disease onset In a landmark effort, the INTERCEPT project has launched Europe’s first biomarker trial aimed at preventing Crohn’s Disease before symptoms start. This initiative, funded by …